Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228

Improved cancer diagnostics — and improved patient outcomes — could be among the changes generative AI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Paige cofounder and Chief Scientific Officer Thomas Fuchs. He’s also dean of artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai. Tune in to hear Fuchs on machine learning and AI applications and how technology brings better precision and care to the medical industry.

Om Podcasten

One person, one interview, one story. Join us as we explore the impact of AI on our world, one amazing person at a time -- from the wildlife biologist tracking endangered rhinos across the savannah here on Earth to astrophysicists analyzing 10 billion-year-old starlight in distant galaxies to the Walmart data scientist grappling with the hundreds of millions of parameters lurking in the retailer’s supply chain. Every two weeks, we’ll bring you another tale, another 25-minute interview, as we build a real-time oral history of AI that’s already garnered nearly 3.4 million listens and been acclaimed as one of the best AI and machine learning podcasts. Listen in and get inspired. https://blogs.nvidia.com/ai-podcast/